CF
SANA icon

Corebridge Financial’s Sana Biotechnology SANA Stock Holding History

Corebridge Financial’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-64,767
Closed -$109K – 2273
2025
Q1 		$109K Sell
64,767
-960
-1% -$2.68K ﹤0.01% 2393
2024
Q4 		$107K Sell
65,727
-4,962
-7% -$14.8K ﹤0.01% 2518
2024
Q3 		$294K Sell
70,689
-435
-0.6% -$2.29K ﹤0.01% 2002
2024
Q2 		$388K Buy
+71,124
New +$567K ﹤0.01% 1825

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Corebridge Financial's SANA Position: Q2 2025 in Review

Corebridge Financial sold out of Sana Biotechnology (SANA) in Q2 2025, closing a stake of 64,767 shares — an estimated $109K sold.

Corebridge Financial first reported a position in SANA in Q2 2024 and held it in 4 quarters. The position peaked at $388K in Q2 2024. 155 funds tracked by Wall St. Rank hold SANA as of Q2 2025.

  • Corebridge Financial reported no remaining Sana Biotechnology position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 64,767 Sana Biotechnology shares in Q2 2025, an estimated $109K.
  • Corebridge Financial first reported a position in Sana Biotechnology in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Sana Biotechnology position peaked at $388K in Q2 2024.
  • 155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.